You are here:

bilastine (Ilaxten®)

Advice

in the absence of a submission from the holder of the marketing authorisation:

bilastine (Ilaxten®) is not recommended for use within NHS Scotland.

Indication under review: symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: bilastine (Ilaxten®)
SMC Drug ID: 730/11
Manufacturer: A Menarini Pharmaceuticals UK Ltd
Indication: Symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria
BNF Category:
Sub Category: 3.4 Antihistamines hyposensitisation and allergic emergencies
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 8 August 2011

Back